More on thrombolytic therapy for acute stroke.
Sluss
M P
MP
D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D006801:Humans; D011994:Recombinant Proteins; D015912:Thrombolytic Therapy / Q000009:adverse effects; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use
D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator